<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03926884</url>
  </required_header>
  <id_info>
    <org_study_id>A1248</org_study_id>
    <nct_id>NCT03926884</nct_id>
  </id_info>
  <brief_title>Evaluation of the Three-Seeds Mixture Treatment in Chronic Obstructive Pulmonary Disease Patients</brief_title>
  <official_title>Evaluation of the Three-Seeds Mixture Treatment in Chronic Obstructive Pulmonary Disease Patients: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Veterans Affairs Medical Center, Miami</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dr. Robert Jackson</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Veterans Affairs Medical Center, Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test whether the three-seeds mixture tea reduces sputum
      and/or cough in COPD patients, and if so, to evaluate whether the three-seeds mixture changes
      the lung microbiome.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sputum and cough score</measure>
    <time_frame>One month</time_frame>
    <description>Sputum and cough measured by Cough and Sputum Assessment Questionnaire. The minimum score of this questionnaire is 0, and the maximum score is 100, with lower scores indicating higher symptom/impact levels. The total score will be reported. The score will be summed to a total score.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cough</condition>
  <arm_group>
    <arm_group_label>Tea1 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is the treatment group. This group will be taking 2 grams of the &quot;three-seeds&quot; mixture twice a day for three weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tea2 group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This is the control group. This group will be taking 0.02 grams of the &quot;three-seeds&quot; mixture once a day for three weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Three-seeds mixture</intervention_name>
    <description>mixture of white mustard seeds, radish seeds and beefsteak plant (Korean perilla, a species of Perilla in the mint family, widely cultivated and edible for humans; a daily food for Korean people; many Japanese people drink as tea) seeds</description>
    <arm_group_label>Tea1 group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>warm water with negligible amount of the three-seeds mixture</description>
    <arm_group_label>Tea2 group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Males or females ages 50-80 at the time of entry

          2. Non-smoker for at least 1 year

          3. Chronic bronchitis with Fev1 &lt;80% and Fev1/ Fvc &lt;0.7 and daily sputum production

          4. Documentation of COPD. We define COPD as the presence of irreversible airflow
             obstruction, presence of emphysema on CT scan or both. This determination will be by
             the pulmonary physicians leading this study.

          5. Ability and willingness to provide informed consent.

        Exclusion Criteria:

        1. Current Smoker 2. Asthma or other respiratory diseases 3. Frail patients (unintended
        weight loss, long term fatigue). 4. Patients with acute COPD exacerbation

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 10, 2019</study_first_submitted>
  <study_first_submitted_qc>April 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2019</study_first_posted>
  <last_update_submitted>April 22, 2019</last_update_submitted>
  <last_update_submitted_qc>April 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Veterans Affairs Medical Center, Miami</investigator_affiliation>
    <investigator_full_name>Fei Tang</investigator_full_name>
    <investigator_title>Research Health Scientist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

